Brian Thompson - UnitedHealth Group Ex UnitedHealthcare
| UNHH34 Stock | 51.82 1.32 2.61% |
Insider
Brian Thompson is Ex UnitedHealthcare of UnitedHealth Group Incorporated
| Phone | 952 936 1300 |
| Web | https://www.unitedhealthgroup.com |
UnitedHealth Group Management Efficiency
The company has return on total asset (ROA) of 0.0776 % which means that it generated a profit of $0.0776 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2535 %, meaning that it generated $0.2535 on every $100 dollars invested by stockholders. UnitedHealth Group's management efficiency ratios could be used to measure how well UnitedHealth Group manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Vinicius Albernaz | Odontoprev SA | 48 | |
| Andre Schulten | The Procter Gamble | 52 | |
| Leonardo Arajo | Plano Plano Desenvolvimento | N/A | |
| Ana Carracedo | Qualicorp Consultoria e | N/A | |
| Manoel Peres | Odontoprev SA | 56 | |
| Mauro Sampaio | Qualicorp Consultoria e | N/A | |
| Rodrigo Bacellar | Odontoprev SA | 57 | |
| Jerome Abelman | British American Tobacco | 59 | |
| Matthew Janzaruk | The Procter Gamble | 49 | |
| Heraclito Gomes | Qualicorp Consultoria e | 51 | |
| Rodrigo Luna | Plano Plano Desenvolvimento | N/A | |
| Paul Lageweg | British American Tobacco | 53 | |
| Pablo Meneses | Qualicorp Consultoria e | N/A | |
| Susan Whaley | The Procter Gamble | 49 | |
| Joao Neto | Qualicorp Consultoria e | N/A | |
| Vittorio Cretella | The Procter Gamble | N/A | |
| Luiz Cappi | Odontoprev SA | 75 | |
| Hae Kim | British American Tobacco | 49 | |
| Carlos Neto | Qualicorp Consultoria e | N/A | |
| Franco Abelardo | Qualicorp Consultoria e | N/A | |
| Renato Costa | Odontoprev SA | 32 | |
Management Performance
| Return On Equity | 0.25 | |||
| Return On Asset | 0.0776 |
UnitedHealth Group Leadership Team
Elected by the shareholders, the UnitedHealth Group's board of directors comprises two types of representatives: UnitedHealth Group inside directors who are chosen from within the company, and outside directors, selected externally and held independent of UnitedHealth. The board's role is to monitor UnitedHealth Group's management team and ensure that shareholders' interests are well served. UnitedHealth Group's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, UnitedHealth Group's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Dirk McMahon, Pres COO | ||
| John Rex, Ex CFO | ||
| Zachary Sopcak, VP Relations | ||
| Jennifer Smoter, VP Officer | ||
| Rupert Bondy, Ex Officer | ||
| Sandeep Dadlani, Ex Officer | ||
| Sir Witty, CEO Director | ||
| Thomas Roos, VP Officer | ||
| Brian Thompson, Ex UnitedHealthcare | ||
| James Barry, Director Pennsylvania |
UnitedHealth Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is UnitedHealth Group a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.25 | |||
| Return On Asset | 0.0776 | |||
| Profit Margin | 0.06 % | |||
| Operating Margin | 0.09 % | |||
| Current Valuation | 2.7 T | |||
| Shares Outstanding | 65.4 B | |||
| Price To Book | 6.68 X | |||
| Price To Sales | 8.35 X | |||
| Revenue | 322.13 B | |||
| Gross Profit | 79.62 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Information and Resources on Investing in UnitedHealth Stock
When determining whether UnitedHealth Group offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of UnitedHealth Group's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Unitedhealth Group Incorporated Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Unitedhealth Group Incorporated Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in UnitedHealth Group Incorporated. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.